Recruiting OBSERVATIONAL NCT07046689
PET/CT for Trop2 ADC Response Evaluation Cancers
Evaluation of Treatment Response to Trop2 ADC by 68Ga-MY6349 PET/CT in Advanced Breast Cancer
Sponsor: The First Affiliated Hospital of Xiamen University
Conditions
Breast Cancer PET/CT Trop2
Interventions
68Ga-MY6349 PET/CT
Updated 1 time since 2025 Last updated: Jul 14, 2025 Started: Nov 1, 2024 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Breast Cancer and PET/CT, this trial is actively recruiting participants. The trial is conducted by The First Affiliated Hospital of Xiamen University and has accumulated 1 data snapshot since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- The First Affiliated Hospital of Xiamen University
Data source: The First Affiliated Hospital of Xiamen University
For direct contact, visit the study record on ClinicalTrials.gov .